Announcements

** Molluscum Contagiosum: Low-Dose Alpha Interferon Trial,
San Francisco

Persons with moderate or severe molluscum contagiosum which has failed other treatments may be eligible for a clinical trial of low-dose alpha interferon (5 million units daily by subcutaneous injection). The trial is sponsored by the Community Consortium; volunteers will be seen at the Dermatology Clinic at San Francisco General Hospital, and will learn to inject themselves so they can take the medicine at home. The trial will last eight weeks. Any antiretroviral therapy (AZT, ddI, or ddC) is OK during the trial.

For more information, call Marcela Mirda, R. N., 415/476- 9554.

** The Positive Woman: Phone Number Correction;
Washington, D. C., Meeting

In issue #130, AIDS TREATMENT NEWS published an incorrect phone number for The Positive Woman, a newsletter by and for HIV- positive women and their families and friends. The correct phone number is 202/898-0372.

Note: On Wednesday, August 28, The Positive Woman and other organizations will sponsor a report on the Seventh International Conference on AIDS, June 1991 in Florence. The meeting will be 6:30 to 8:30 p.m. at the Martin Luthor King Memorial Library in Washington, D. C. For more information, call The Positive Woman at the number above.

** Azithromycin Available

In the last issue of AIDS TREATMENT NEWS we said that we had not heard of buyers' club access for azithromycin, an experimental treatment for toxoplasmosis and also for MAC. Since then we have learned that the PWA Health Group in New York, 212/532-0280, can help people import the drug for personal use. As we said in the last issue, azithromycin is also available through a compassionate-use program from Pfizer Inc., its developer, for treatment of some cases of toxoplasmosis.




AIDS TREATMENT NEWS Published twice monthly Subscription and Editorial Office:
P. O. Box 411256
San Francisco, CA 94141
800/TREAT-1-2 toll-free U. S. and Canada
415/255-0588 regular office number
415/255-4659 fax Editor and Publisher:
John S. James Medical Reporters:
John S. James
Michelle Roland
Denny Smith Reader Services, Business, and Marketing:
Thom Fontaine
Keith Griffith
Laura Thomas
Tadd Tobias
Tim Wilson Statement of Purpose: AIDS TREATMENT NEWS reports on experimental and standard treatments, especially those available now. We interview physicians, scientists, other health professionals, and persons with AIDS or HIV; we also collect information from meetings and conferences, medical journals, and computer databases. Long-term survivors have usually tried many different treatments, and found combinations which work for them. AIDS Treatment News does not recommend particular therapies, but seeks to increase the options available.

Subscription Information: Call 800/TREAT-1-2
Businesses, Institutions, Professionals: $200/year.
Nonprofit organizations: $100/year.
Individuals: $100/year, or $55 for six months.
Special discount for persons with AIDS or HIV with
financial difficulties: $40/year, or $20 for six months.
If you cannot afford a subscription, please write or call.
Outside North, Central, or South America, add air mail
postage: $20/year, $10 for six months.
Back issues available.
Canadians add 7% Goods and Services Tax.
Bulk rate: five or more non-discount orders, 40%
savings. For larger orders, contact our office.
Please send U. S. funds: personal check or bank draft,
international postal money order, or travelers checks.
VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

Copyright 1991 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.